Fatigue, a common symptom reported in clinical practice, often poses a diagnostic challenge due to its multifactorial etiology. A thorough understanding of its underlying mechanisms and a comprehensive clinical approach are crucial for effective management.
Fatigue can be classified into physical and mental, each with distinct pathophysiological mechanisms. Physical fatigue, often resulting from strenuous physical activity, is associated with muscle weakness and a lack of energy. Mental fatigue, on the other hand, manifests as difficulty in concentrating, memory impairment, and a decreased mental stamina. It is important to distinguish between the two as their management strategies differ significantly.
A detailed history and physical examination form the cornerstone of fatigue evaluation. The history should encompass the onset, duration, severity, and impact of fatigue on daily activities. Associated symptoms, psychosocial factors, and past medical history should also be considered. Physical examination should focus on signs of systemic diseases that could manifest as fatigue. Laboratory investigations are guided by clinical suspicion and may include complete blood count, thyroid function tests, and markers of inflammation.
Management of fatigue should be individualized, addressing the underlying cause and associated symptoms. Non-pharmacological interventions, including lifestyle modifications and cognitive-behavioral therapy, form the first line of management. Pharmacological therapy, such as stimulants, may be considered in refractory cases or when an underlying medical condition necessitates it.
Fatigue, while common, can be a manifestation of underlying serious conditions. A comprehensive clinical approach, encompassing a thorough history, physical examination, and targeted investigations, is essential in identifying the etiology. Management should be individualized, addressing the root cause and improving the patient's quality of life. Ongoing research in this field promises to enhance our understanding and management of this complex symptom.
1.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
2.
FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer
3.
How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
4.
AI-based liquid biopsy shows promise for detecting brain cancer
5.
The Kansas Cancer Center awarded two Indian American doctors professorships.
1.
Clinical Guidelines for Targeting the Tumor Microenvironment in Solid Cancers
2.
Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies
3.
Examining Serum Osmolality: What It Is And How To Test For It
4.
Evolutionary Bottlenecks in Tumor Progression
5.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
2.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Thromboprophylaxis In Medical Settings
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation